Country & Language

WCOM™ in a Global Provider of Services to Pharma

A global provider of integrated services to pharmaceutical and biotech companies faced rapid growth but struggled with performance bottlenecks in order management. Together with EFESO, the organization deployed a WCOM™-based progression plan and sprint approach to reengineer critical processes and established scalable governance structures to sustain future growth.

Life Sciences
Manufacturing
Operational Excellence
Operations Strategy and Transformation
Parallaxe

Our Client

A global provider of integrated services to pharmaceutical and biotechnology companies, supporting the development, manufacturing, and commercialization of drug products. With expanding service capabilities and a rapidly growing customer base, the company requires reliable and agile operations to maintain its competitive edge.

Parallaxe

The Challenge

Rapid expansion and demand acceleration had created critical operational challenges that threatened the company’s scalability and customer reliability. The organization needed a systemic transformation of the order management process to support its growth trajectory and strategic ambitions.

Key blockers included:

  • Reliability constraints: Inconsistent performance impacted customer expectations and service commitments
  • Order management complexity: Fragmented workflows and unclear accountability led to delays and rework
  • Limited visibility and KPIs: Absence of a unified measurement model hindered progress tracking and decision-making
  • Leadership adoption gap: Lack of reinforced behaviors and routines prevented sustainable improvement

Real Results Achieved Together

The WCOM™ sprint and progression plan created a clear connection between strategic objectives and operational excellence, enabling tangible performance improvements and preparing the organization for accelerated growth.

+30%

OTIF improvement

~95%

OTIF target achieved

Transformation Impact

  • Detailed 4-Dynamics (Value, Flow, Asset, Human) process assessment of Order Management
  • Weekly Planning cycle redesign and effective meeting frameworks implementation
  • PCS for loss eradication to meet target of approximately 95 percent
  • Lead time control for sub-process steps, order processing, document generation, review and approval, purchasing, QC, QA


Parallaxe

Our Approach

EFESO deployed a structured WCOM™ methodology to diagnose growth blockers and redesign order management systems. The approach combined process engineering, governance routines, and leadership adoption to accelerate results.

Key elements included:

  • Development of a business progression plan connecting strategic objectives to measurable operational activities
  • Comprehensive process reengineering with KPI definitions for OTIF, lead time, and quality metrics
  • Introduction and coaching of High Impact Meetings to reinforce decision-making and build a continuous improvement cadence
  • A 4-Dynamic assessment (Value, Flow, Asset, Human) to identify systemic constraints and improvement levers
  • Weekly planning cycles and structured meeting frameworks for planning, accountability, and loss eradication
  • Deployment of PCS (Performance Control System) for systematic loss capture and problem resolution

This integrated model created a repeatable and scalable performance system aligned with the organization’s rapid growth trajectory.

Related Services

Aging equipment meets rising costs and technology disruption. We transform operations through smart factory integration, predictive maintenance, and workforce capability building.
Parallaxe

Ready to Transform Growth Blockers Into Competitive Advantages?

  • Achieve operational excellence that scales with your growth ambitions
  • Stop letting process inefficiencies limit your market potential
  • Join pharma leaders who've unlocked sustainable performance improvements


Contact our experts

Discover More Clients Results

45K m²
Optimized factory layout (reduced from 52K m²)
Industrial Manufacturing

Creating a solid, structured plan for the material flow of its production and validated the static forecast, enabling the factory to increase the output with the existing machinery.

13%
Reduction in release time for high-value APIs
Chemicals
Life Sciences

A QC lab optimization framework helps a multinational chemical-pharmaceutical company achieved simultaneous gains in productivity, service level, and resource efficiency, delivering measurable improvements in release time, productivity, and FTE requirements without compromising quality.